Experienced in Immunodeficiency with Hyper IgM Type 1

Dr. Timothy J. Craig

Allergy and Immunology
The Milton S Hershey Medical Center Physicians Group
500 University Dr, 
Hershey, PA 
Experienced in Immunodeficiency with Hyper IgM Type 1
The Milton S Hershey Medical Center Physicians Group
500 University Dr, 
Hershey, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Timothy Craig is an Allergy and Immunologist in Hershey, Pennsylvania. Dr. Craig is rated as an Experienced provider by MediFind in the treatment of Immunodeficiency with Hyper IgM Type 1. His top areas of expertise are Hereditary Angioedema, Angioedema, Hives, Asthma, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 298 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Internal Medicine in PA
Hospital Affiliations
Milton S Hershey Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

THE MILTON S HERSHEY MEDICAL CENTER PHYSICIANS GROUP
500 University Dr, Hershey, PA 17033

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Systemic Allergic Reactions to SARS-CoV-2 Vaccination
Systemic Allergic Reactions to SARS-CoV-2 Vaccination
Enrollment Status: Completed
Publish Date: August 12, 2025
Intervention Type: Biological
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Biological, Other
Study Drug: Prolastin C
Study Phase: Phase 3
An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)
An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)
Enrollment Status: Completed
Publish Date: March 30, 2023
A Phase 3, Multicenter, Open-Label Study of the Safety, Tolerability, Efficacy, and PK of ProMetic BioTherapeutics IGIV (Human) 10% in Adults and Children With Primary Immunodeficiency Diseases
A Phase 3, Multicenter, Open-Label Study of the Safety, Tolerability, Efficacy, and PK of ProMetic BioTherapeutics IGIV (Human) 10% in Adults and Children With Primary Immunodeficiency Diseases
Enrollment Status: Completed
Publish Date: November 05, 2021
Intervention Type: Biological
Study Phase: Phase 3
TITLE: Double-blinded, Double-dummy, Study Comparing Fluticasone-salmeterol to Placebo in Patients With COPD and Associated Poor Sleep or Daytime Somnolence.
TITLE: Double-blinded, Double-dummy, Study Comparing Fluticasone-salmeterol to Placebo in Patients With COPD and Associated Poor Sleep or Daytime Somnolence.
Enrollment Status: Completed
Publish Date: March 29, 2019
Intervention Type: Drug
Study Phase: Phase 4
Z4770s, Use of Recombinant Human DNASE in Cystic Fibrosis Patients With Chronic Sinusitis to Prevent Acute Sinusitis Exacerbations and Improve Symptoms and Outcomes - A Pilot Study
Z4770s, Use of Recombinant Human DNASE in Cystic Fibrosis Patients With Chronic Sinusitis to Prevent Acute Sinusitis Exacerbations and Improve Symptoms and Outcomes - A Pilot Study
Enrollment Status: Withdrawn
Publish Date: July 21, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

297 Total Publications

Self-Administered Home Sleep Testing Model in Screening of OSA in Healthcare Workers-Sohew Study: A National Multicenter Study in Vietnam.
Self-Administered Home Sleep Testing Model in Screening of OSA in Healthcare Workers-Sohew Study: A National Multicenter Study in Vietnam.
Journal: Pulmonary therapy
Published: July 15, 2025
Similar Doctors
Experienced in Immunodeficiency with Hyper IgM Type 1
Dr. Laura H. Fisher
Allergy and Immunology
Experienced in Immunodeficiency with Hyper IgM Type 1
Dr. Laura H. Fisher
Allergy and Immunology

Lancaster Family Allergy LLC

730 Eden Rd, Suite 301, 
Lancaster, PA 
 (24.4 miles away)
717-569-5618
Languages Spoken:
English
See accepted insurances

Laura Fisher is an Allergy and Immunologist in Lancaster, Pennsylvania. Dr. Fisher is rated as an Advanced provider by MediFind in the treatment of Immunodeficiency with Hyper IgM Type 1. Her top areas of expertise are Allergic Rhinitis, Sinusitis, Hives, and Grass Allergy.

Experienced in Immunodeficiency with Hyper IgM Type 1
Dr. David M. Anmuth
Pediatric Allergy and Immunology | Pediatrics | Allergy and Immunology
Experienced in Immunodeficiency with Hyper IgM Type 1
Dr. David M. Anmuth
Pediatric Allergy and Immunology | Pediatrics | Allergy and Immunology

Geisinger Clinic

100 N Academy Ave, 
Danville, PA 
 (48.8 miles away)
570-271-6541
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Anmuth is a Pediatric Allergy and Immunologist and a Pediatrics provider in Danville, Pennsylvania. Dr. Anmuth is rated as an Advanced provider by MediFind in the treatment of Immunodeficiency with Hyper IgM Type 1. His top areas of expertise are Grass Allergy, Selective Deficiency of IgA, Chronic Spontaneous Urticaria (CSU), and Vibratory Urticaria.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Craig's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 24 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile